Metamizol Slavia

Metamizole sodium, the active ingredient in Metamizol Slavia, is a pyrazolone presented as an oral dosage form for oral use. It provides analgesic and antipyretic effects for the treatment of pain, fever, and colic in adults.

GNH USA supplies Metamizol Slavia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizol Slavia is used for conditions that involve acute pain, fever, or visceral colic, acting through inhibition of prostaglandin synthesis and modulation of opioid pathways.

- Pain: reduces moderate to severe acute pain when other analgesics are insufficient. - Fever: lowers elevated body temperature in febrile states. - Colic: alleviates severe abdominal cramping associated with gastrointestinal or biliary colic.

Metamizol Slavia may cause a range of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Vomiting: occasional emesis. - Dizziness: transient light‑headedness. - Rash: mild skin erythema. - Hypotension: temporary drop in blood pressure. - Transient leukopenia: short‑term reduction in white blood cells.

Serious or Rare Side Effects: - Agranulocytosis: severe depletion of neutrophils, potentially life‑threatening. - Anaphylaxis: acute allergic reaction with airway compromise. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: liver enzyme elevation or injury. - Hemolytic anemia: destruction of red blood cells. - Thrombocytopenia: low platelet count leading to bleeding risk.

When prescribing Metamizol Slavia, clinicians should consider patient history and monitor for adverse events.

- Blood monitoring: perform regular complete blood counts to detect agranulocytosis early. - Renal function: assess kidney function in patients with pre‑existing renal impairment. - Hepatic function: evaluate liver enzymes before and during therapy. - Allergy history: avoid use in individuals with known hypersensitivity to pyrazolones. - Concomitant drugs: review other medications that may affect bone marrow or immune function. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Metamizol Slavia can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants: increased bleeding risk due to platelet inhibition. - Immunosuppressants: heightened risk of severe neutropenia. - Other myelosuppressive agents: additive bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - NSAIDs: potential additive gastrointestinal irritation. - ACE inhibitors: possible enhancement of hypotensive effects. - Diuretics: may exacerbate electrolyte disturbances. - Antihypertensives: monitor for additive blood‑pressure lowering.